ÂÜÀòÂÒÂ×

Heli Huopaniemi has a diverse work experience spanning various companies. Heli is currently working at Revenio Group Oyj, where they started as the Director of Quality Assurance in February 2018 and later became the Vice President of Quality in February 2022. Prior to this, they worked at Icare Finland Oy as the QA Manager starting in March 2010. Before that, they were the QA Manager at PlexPress Oy from January 2009 to March 2010. Heli co-founded CTT Cancer Targeting Technologies in 2002, where they served as the Chief Technological Officer until 2008.

Heli Huopaniemi obtained their Master's Degree in Biochemistry from the University of Helsinki, where they studied from 1992 to 1997. In September 2010, they also obtained a Lead Auditor certification from Laatukeskus.